Bell’s palsy is a chronic medical condition that causes temporary weakness or paralysis of the facial muscles. Bell’s palsy generally occurs when the nerves that control the facial muscles become inflamed, swollen, or compressed. Patients suffering from Bell’s palsy find it difficult to smile or close their eyes as it affects one side of face. Bell’s palsy is common among people aged between 16 to 60 years. It usually occurs after the patient suffers from cold, ear infection or eye infection for one or two weeks or more. However, the exact cause of damage of the cranial nerve due to Bell’s palsy is still unknown. Patients suffering from diabetes or lung infection are highly susceptible to Bell’s palsy.
To remain ‘ahead’ of your competitors, request a sample https://www.factmr.com/connectus/sample?flag=S&rep_id=1291
Bell’s palsy is diagnosed by various blood tests to check the presence of bacterial or viral infection. MRI or CT is also used for the final diagnosis of Bell’s palsy by scanning the nerves of patients. Corticosteroids and anticonvulsants are used as the first line of treatment by physicians for the treatment of Bell’s palsy. These drugs are given in combination with anti-bacterial and anti-viral medications. Over-the-counter pain medications, such as ibuprofen or acetaminophen, can also be used by patients for temporary relief from Bell’s palsy. Moreover, eye drops and ear drops are also used along with these medications if the root cause of Bell’s palsy is ear or eye infection. Various home remedies are also used by patients to manage Bell’s palsy, such as facial massage, physical therapy exercises, a warm & moist towel over your face to relieve pain, etc.
Bell’s Palsy Treatment Market: Drivers and Restraints
The primary factor driving the Bell’s palsy treatment market is the increasing prevalence of ear and eye infections, which are the major causes of Bell’s palsy. Moreover, unfavourable changes in the lifestyles of people is also boosting the prevalence of Bell’s palsy. Rising awareness among the people about the Bell’s palsy treatment is also expected to increase its demand over the forecast period. In addition, high focus of leading pharmaceutical companies to manufacture the more improved drugs for Bell’s palsy treatment will also be responsible for the robust growth of this market. On other hand, the ignorance of patients about opting for Bell’s palsy treatment during the early onset of the disease is likely to restrain market growth. Moreover, lack of approved drugs for the appropriate Bell’s palsy treatment is also likely to hamper the growth of this market to a certain extent.
Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1291
Bell’s Palsy Treatment Market: Segmentation
The global Bell’s palsy treatment market can be segmented on the basis of drug class, distribution channel and geography.
Based on drug class type, the global Bell’s palsy treatment market is segmented as:
Based on distribution channel, the global Bell’s palsy treatment market is segmented as:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Bell’s Palsy Treatment Market: Overview
The Bell’s palsy treatment market is expected to witness exponential growth over the forecast period owing the rising prevalence of Bell’s palsy. According to some studies, the annual incidence of Bell’s palsy is 15-30 cases per 100,000 population. Bell’s palsy is most prevalent among the geriatric population.
For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=1291
The leading drug manufacturers of Bell’s palsy treatment are focus to develop more improved drugs to boost their market share. Large funding is provided by investors and the government for research and development to develop more appropriate drugs for Bell’s palsy treatment. By drug class, corticosteroids and anticonvulsants are expected to collectively gain majority of the revenue share of the global Bell’s palsy treatment market. Among all end users, online pharmacies is the fastest-growing segment due to the rising adoption of e-commerce.
Bell’s palsy Treatment Market: Regional Outlook
Geographically, the global Bell’s palsy treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to gain maximum market share in terms of revenue owing to awareness among the people about Bell’s palsy treatment. The North America Bell’s palsy treatment market is followed by Western Europe and Eastern Europe owing to the presence of the maximum number of pharmaceutical companies in these regions. The Asia-Pacific excluding Japan region is expected to grow at a faster rate as compared to other regions due to the rising incidence of Bell’s palsy. In APEJ, Bell’s palsy is most prevalent in India and China. However, Latin America and Middle East & Africa are expected witness delayed growth due to lack of awareness among the people in these regions.
Bell’s Palsy Treatment Market: Key Players
Some of the key players operating in the global Bell’s palsy treatment market are Pfizer Inc.; Bristol-Myers Squibb and Company; Eli Lily and Company; Johnson & Johnson Services, Inc.; GlaxoSmithKline PLC; Bayer AG; Sanofi S.A.; Novartis AG; Teva Pharmaceutical Industries Ltd. and Gilead Sciences, Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583